Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 43.9
(2.81%)
TWD 43.9
(2.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.21 Billion TWD | 16.15% |
| 2022 | -1.44 Billion TWD | -202.22% |
| 2021 | 1.41 Billion TWD | 315.29% |
| 2020 | -657.86 Million TWD | -9.9% |
| 2019 | -598.59 Million TWD | -28.36% |
| 2018 | -466.33 Million TWD | -38.77% |
| 2017 | -336.03 Million TWD | -53.04% |
| 2016 | -219.58 Million TWD | -19.84% |
| 2015 | -183.23 Million TWD | -69.11% |
| 2014 | -108.35 Million TWD | -41.25% |
| 2013 | -76.7 Million TWD | -248.59% |
| 2012 | -22 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.66 Million TWD | 97.5% |
| 2024 Q1 | -106.7 Million TWD | 80.45% |
| 2024 Q3 | 8.65 Million TWD | 424.41% |
| 2023 Q4 | -545.82 Million TWD | -1183.31% |
| 2023 Q1 | -202.89 Million TWD | 71.33% |
| 2023 Q3 | -42.53 Million TWD | 86.01% |
| 2023 Q2 | -304.12 Million TWD | -49.89% |
| 2023 FY | -1.21 Billion TWD | 16.15% |
| 2022 Q4 | -707.72 Million TWD | -136.01% |
| 2022 Q2 | -301.54 Million TWD | -117.64% |
| 2022 Q1 | -138.54 Million TWD | -112.98% |
| 2022 FY | -1.44 Billion TWD | -202.22% |
| 2022 Q3 | -299.86 Million TWD | 0.55% |
| 2021 Q2 | -455.03 Million TWD | -60.7% |
| 2021 Q4 | 1.06 Billion TWD | 63.36% |
| 2021 Q1 | -283.16 Million TWD | -9.09% |
| 2021 FY | 1.41 Billion TWD | 315.29% |
| 2021 Q3 | 653.31 Million TWD | 243.57% |
| 2020 Q3 | -204.45 Million TWD | -18.45% |
| 2020 FY | -657.86 Million TWD | -9.9% |
| 2020 Q2 | -172.6 Million TWD | -35.65% |
| 2020 Q1 | -127.24 Million TWD | 31.77% |
| 2020 Q4 | -259.56 Million TWD | -26.95% |
| 2019 Q3 | -121.89 Million TWD | 23.2% |
| 2019 FY | -598.59 Million TWD | -28.36% |
| 2019 Q4 | -186.5 Million TWD | -53.0% |
| 2019 Q2 | -158.71 Million TWD | -16.02% |
| 2019 Q1 | -136.79 Million TWD | 15.19% |
| 2018 Q4 | -161.29 Million TWD | -78.18% |
| 2018 FY | -466.33 Million TWD | -38.77% |
| 2018 Q2 | -128.13 Million TWD | -48.34% |
| 2018 Q1 | -86.37 Million TWD | 22.21% |
| 2018 Q3 | -90.52 Million TWD | 29.35% |
| 2017 FY | -336.03 Million TWD | -53.04% |
| 2017 Q4 | -111.03 Million TWD | -44.02% |
| 2017 Q2 | -80.21 Million TWD | -18.51% |
| 2017 Q3 | -77.09 Million TWD | 3.89% |
| 2017 Q1 | -67.68 Million TWD | 23.83% |
| 2016 Q4 | -88.86 Million TWD | -113.49% |
| 2016 Q3 | -41.62 Million TWD | 6.56% |
| 2016 Q1 | -44.54 Million TWD | -4.02% |
| 2016 Q2 | -44.54 Million TWD | 0.0% |
| 2016 FY | -219.58 Million TWD | -19.84% |
| 2015 Q3 | -42.82 Million TWD | 12.23% |
| 2015 Q1 | -48.79 Million TWD | -72.12% |
| 2015 Q2 | -48.79 Million TWD | 0.0% |
| 2015 FY | -183.23 Million TWD | -69.11% |
| 2015 Q4 | -42.82 Million TWD | 0.0% |
| 2014 FY | -108.35 Million TWD | -41.25% |
| 2014 Q4 | -28.34 Million TWD | 0.0% |
| 2014 Q3 | -28.34 Million TWD | -9.75% |
| 2014 Q2 | -25.82 Million TWD | 0.0% |
| 2014 Q1 | -25.82 Million TWD | 0.0% |
| 2013 FY | -76.7 Million TWD | -248.59% |
| 2012 FY | -22 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 530.663% |
| Level Biotechnology Inc. | 67.55 Million TWD | 1896.881% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -1785.53% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | -1328.976% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | -429.397% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -1328.135% |
| Visgeneer Inc. | -21.15 Million TWD | -5636.703% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 235.654% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 1604.423% |
| Neith Corporation | -48.85 Million TWD | -2384.605% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -18263.525% |
| Enimmune corporation | -243.47 Million TWD | -398.544% |
| TaiRx, Inc. | -214.69 Million TWD | -465.374% |
| EirGenix Inc. | -1.03 Billion TWD | -17.622% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 2016.522% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | -1583.629% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -1200.494% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | -587.562% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 5123.711% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -2686.568% |
| RBC Bioscience Corporation | 14.53 Million TWD | 8448.779% |
| BiOptic Inc. | 44.05 Million TWD | 2855.383% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -2038.943% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -1836.456% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -1744.164% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 463.333% |
| Mycenax Biotech Inc. | -602.1 Million TWD | -101.599% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -1619.743% |
| TaiMed Biologics Inc. | -166.23 Million TWD | -630.206% |
| GlycoNex Incorporation | -259.86 Million TWD | -367.102% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -53776.121% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -2567.639% |
| Lin BioScience, Inc. | -1.09 Billion TWD | -10.667% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | -74.872% |
| VBI | -16.13 Million TWD | -7424.355% |
| CHO Pharma, Inc. | -268.99 Million TWD | -351.241% |
| NaviFUS Corp. | -76.42 Million TWD | -1488.241% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -1191.926% |
| Sinew Pharma Inc. | -186.25 Million TWD | -551.71% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -1693.032% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 859.512% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | -223.149% |
| AP Biosciences Inc | -347.47 Million TWD | -249.325% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 1.562% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -1831.219% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -42882.613% |
| Intech Biopharm Corporation | -304.39 Million TWD | -298.766% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | -10.688% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -2826.158% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | -615.887% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 459.406% |
| TCI GENE Inc. | 10.04 Million TWD | 12179.102% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -853.841% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | -290.159% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | -472.01% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 35447.379% |
| PharmaEngine, Inc. | 277.18 Million TWD | 537.916% |
| Savior Lifetec Corporation | -2.42 Million TWD | -50058.223% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | -594.812% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 41.916% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | -885.619% |
| Acepodia, Inc. | -435.97 Million TWD | -178.418% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | -148.757% |